Hematopathologic findings in the myeloproliferative disorders.
In the preceding paragraphs, the features that define the various members of the CMPD have been reviewed. These features are summarized in Table 4. Knowledge of these guidelines will aid the clinician and pathologist in arriving at a proper classification; however, in most cases, it is the occasional patient whose clinical, laboratory, and morphologic findings lie across the different categories that unifies these CMPDs, and that provides the challenge which makes them interesting.
Dickstein
J I
JI
Department of Pathology, University of Chicago, IL 60637, USA.
Vardiman
J W
JW
D001853:Bone Marrow / Q000473:pathology; D002908:Chronic Disease; D003937:Diagnosis, Differential; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000145:classification / Q000473:pathology; D009196:Myeloproliferative Disorders / Q000097:blood* / Q000145:classification / Q000235:genetics / Q000473:pathology*; D011087:Polycythemia Vera / Q000097:blood / Q000473:pathology; D055728:Primary Myelofibrosis / Q000097:blood / Q000473:pathology; D013922:Thrombocytosis / Q000097:blood / Q000473:pathology